SCHEMBL6676526

SCHEMBL6676526

O=C(O)N(CCCNc1nc2ccccc2[n+]([O-])n1)CCCNc1nc2ccccc2[n+]([O-])n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.41
BCHE P06276 2/20 0.37
ACHE P22303 1/20 0.37
POLB P06746 2/20 0.36
RAD52 P43351 2/20 0.36
NPC1 O15118 1/20 0.36
SLC2A1 P11166 1/20 0.36
APOBEC3A P31941 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
HPGD P15428 3/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
REN P00797 1/20 0.35
KDM1A O60341 1/20 0.35
EHMT2 Q96KQ7 1/20 0.35
RCOR1 Q9UKL0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6679508 0.93 IDO1 (0.41) IDO1BCHEACHEPOLBRAD52
SCHEMBL5455035 0.90 IDO1 (0.41) IDO1BCHEACHEPOLBNPC1
SCHEMBL6676529 0.85 IDO1 (0.39) IDO1BCHEACHEPOLBKMT2A
SCHEMBL6676039 0.83 RAD52 (0.48) IDO1POLBRAD52KMT2AHPGD
SCHEMBL5450923 0.82 IDO1 (0.46) IDO1ACHEPOLBRAD52HPGD
SCHEMBL6675510 0.82 RAD52 (0.51) POLBRAD52NPC1SLC2A1APOBEC3A
SCHEMBL25208697 0.81 ALDH1A1 (0.45) IDO1POLBKMT2AHPGDALDH1A1
SCHEMBL6365368 0.80 POLB (0.49) POLBRAD52SLC2A1RAB9AKMT2A
SCHEMBL6366253 0.80 TSHR (0.53) BCHEACHEPOLBRAD52NPC1
SCHEMBL14428363 0.79 IDO1 (0.47) IDO1BCHEACHEHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1468688-A2 Benzoazine mono-N-oxides and benzoazine 1,4 dioxides and compositions therefrom for the therapeutic use in cancer treatments Auckland Uniservices Limited (NZ) 2004-10-20 EP disclosed